Impact of artificial intelligence assisted lesion detection on radiologists' interpretation at multiparametric prostate MRI.
Authors
Affiliations (10)
Affiliations (10)
- Massachusetts General Hospital, Boston, MA, USA. Electronic address: [email protected].
- Massachusetts General Hospital, Boston, MA, USA. Electronic address: [email protected].
- Massachusetts General Hospital, Boston, MA, USA. Electronic address: [email protected].
- Massachusetts General Hospital, Boston, MA, USA. Electronic address: [email protected].
- Massachusetts General Hospital, Boston, MA, USA. Electronic address: [email protected].
- Massachusetts General Hospital, Boston, MA, USA.
- Siemens Healthineers AG, Forchheim, Germany. Electronic address: [email protected].
- Siemens Healthineers AG, Forchheim, Germany. Electronic address: [email protected].
- Siemens Medical Solutions, Boston, MA, USA. Electronic address: [email protected].
- Massachusetts General Hospital, Boston, MA, USA. Electronic address: [email protected].
Abstract
To compare prostate cancer lesion detection using conventional and artificial intelligence (AI)-assisted image interpretation at multiparametric MRI (mpMRI). A retrospective study of 53 consecutive patients who underwent prostate mpMRI and subsequent prostate tissue sampling was performed. Two board-certified radiologists (with 4 and 12 years of experience) blinded to the clinical information interpreted anonymized exams using the PI-RADS v2.1 framework without and with an AI-assistance tool. The AI software tool provided radiologists with gland segmentation and automated lesion detection assigning a probability score for the likelihood of the presence of clinically significant prostate cancer (csPCa). The reference standard for all cases was the prostate pathology from systematic and targeted biopsies. Statistical analyses assessed interrater agreement and compared diagnostic performances with and without AI assistance. Within the entire cohort, 42 patients (79 %) harbored Gleason-positive disease, with 25 patients (47 %) having csPCa. Radiologists' diagnostic performance for csPCa was significantly improved over conventional interpretation with AI assistance (reader A: AUC 0.82 vs. 0.72, p = 0.03; reader B: AUC 0.78 vs. 0.69, p = 0.03). Without AI assistance, 81 % (n = 36; 95 % CI: 0.89-0.91) of the lesions were scored similarly by radiologists for lesion-level characteristics, and with AI assistance, 59 % (26, 0.82-0.89) of the lesions were scored similarly. For reader A, there was a significant difference in PI-RADS scores (p = 0.02) between AI-assisted and non-assisted assessments. Signficant differences were not detected for reader B. AI-assisted prostate mMRI interpretation improved radiologist diagnostic performance over conventional interpretation independent of reader experience.